Structure Therapeutics Financials - Benzinga

Structure Therapeutics Inc

GPCRNASDAQ

Trade with Public

Trade with Public

$35.93

-0.09-0.25%

近くで: Sep 25, 5:00 PM EST

$35.96

0.030.08%

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Structure Therapeutics Financials

Structure Therapeutics (GPCR) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Structure Therapeutics Q1 EPS $(0.35), Inline

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.35) per share which met the analyst consensus estimate. This is a 29.63 percent decrease over losses of $(0.27) per share from the same period last

Benzinga Newsdesk

PRO
Structure Therapeutics Q4 Adj. EPS $(0.36) Beats $(0.40) Estimate.

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 9.09 percent. This is a 63.64 percent decrease over losses of $(0.22) per share

Benzinga Newsdesk

Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump

Avi Kapoor

PRO
Structure Therapeutics Q2 EPS $(0.36) Misses $(0.25) Estimate

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.25) by 44 percent. This is a 100 percent decrease over losses of $(0.18) per share

Benzinga Newsdesk

PRO
Structure Therapeutics FY 2024 GAAP EPS $(0.78) Beats $(0.80) Estimate

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.80) by 2.5 percent. This is a 3.7 percent increase over losses of $(0.81) per share

Benzinga Newsdesk

PRO
Structure Therapeutics Q3 EPS $(0.20), Inline

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 4.76 percent increase over losses of $(0.21) per share from the same period last

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved